Biotech Growth Exentec operates in biotechnology research with a modest team size (11-50 employees) and a revenue range of 10-25 million, indicating potential need for scalable project management, GMP-compliant software, and mid-market engineering collaborations.

Legacy to Modern The profile notes a transition from Biopharm Engineered Systems to Exentec, suggesting opportunities to position integrated engineering and biotech solutions that support rebranding, knowledge transfer, and unified supply chain software across the enterprise.

Tech Stack Fit Current tools include ERP (Microsoft Dynamics NAV), data visualization (Tableau), design (SOLIDWORKS), SCADA and RSLogix, and development environments. This points to opportunities for MES/ERP integration, data analytics upgrades, and automation software tailored to bioprocessing workflows.

Industry Recognition Recognition as a FOYA Facility of the Future winner via ISPE links Exentec to prestige in bioprocess equipment and facilities, which can be leveraged to cross-sell advanced equipment, validation services, and regulatory-compliant project delivery.

Growth levers With a revenue band in the mid-market and references to suppliers for major players, there is potential to pursue partnerships with large engineering firms or tier-one biopharma OEMs, offering specialized engineering services, systems integration, and scalable manufacturing solutions.